Publication | Open Access

Biweekly high-dose gemcitabine alone or in combination with capecitabine in patients with metastatic pancreatic adenocarcinoma: a randomized phase II trial

OncologyPancreatic CancerGastrointestinal OncologyMetastatic Pancreatic AdenocarcinomaPharmacotherapyCancer TreatmentBiweekly High-dose GemcitabineMedicineRadiation Oncology